Search
for
Sort by
Research 121–150 of 1000+
- Predictors and Management of Inadequate Response to JAK Inhibitors in Alopecia Areata
- Network pharmacology and molecular docking analysis on potential molecular targets and mechanism of action of BRAF inhibitors for application in wound healing
- Janus kinase inhibitors: An innovative treatment for alopecia areata
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors?
- Finasteride inhibits melanogenesis through regulation of the adenylate cyclase in melanocytes and melanoma cells
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- Bisindolylmaleimide Protein-Kinase-C Inhibitors Delay the Decline in DNA Synthesis in Mouse Hair Follicle Organ Cultures
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Art of prevention: The importance of dermatologic care when using aromatase inhibitors
- Network pharmacology-based preventive effect of XZF on cutaneous toxicities induced by EGFR inhibitor
- Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats
- Computer-Aided Designing Peptide Inhibitors of Human Hematopoietic Prostaglandin D2 Synthase Combined Molecular Docking and Molecular Dynamics Simulation
- Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib—A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata
- Phosphodiesterase inhibitors and prostaglandin analogues in dermatology: A comprehensive review
- Eosinophilic folliculitis of the scalp associated with PD‐1/PDL1 inhibitors
- Successive Release of Tissue Inhibitors of Metalloproteinase-1 Through Graphene Oxide-Based Delivery System Can Promote Skin Regeneration
- Epidermal Growth Factor Receptor Inhibitors: Cutaneous Side Effects and Their Management.
- TNF inhibitor induced alopecia: an unusual form of psoriasiform alopecia that breaks the Renbök mold
- Histopathologic features of erythematous papulopustular eruption to epidermal growth factor receptor inhibitors in cancer patients
- Hair loss and Hedgehog inhibitors: a class effect?
- A Phase II Study of Vaginal Testosterone Cream (TEST) vs. Estring for Vaginal Dryness or Decreased Libido in Women with Early Stage Breast Cancer (BC) Treated with Aromatase Inhibitors (AIs).
- Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
- Novel aldo-keto reductase 1C3 inhibitor affects androgen metabolism but not ovarian function in healthy women: a phase 1 study
- JAK Inhibitors: A New Weapon in the Skin Care Providers' Arsenal.
- Dual inhibitors of urease and carbonic anhydrase-II from <i>Iris</i> species
- Paracrine Secreted Frizzled-Related Protein 4 Inhibits Melanocytes Differentiation in Hair Follicle
- Endocrine effects of long-term calcineurin inhibitor use in solid organ transplant recipients
- Janus kinase inhibitors for alopecia areata
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis